These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 3439373)

  • 21. Upper gastrointestinal tolerability of once weekly alendronate 70 mg with concomitant non-steroidal anti-inflammatory drug use.
    Cryer B; Miller P; Petruschke RA; Chen E; Geba GP; Papp AE
    Aliment Pharmacol Ther; 2005 Mar; 21(5):599-607. PubMed ID: 15740544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastrointestinal tract disorder as a side effect of non-steroidal anti inflammatory drugs (NSAIDs).
    Simadibrata M
    Acta Med Indones; 2004; 36(4):195-6. PubMed ID: 15931719
    [No Abstract]   [Full Text] [Related]  

  • 23. Non steroidal anti-inflammatory drugs.
    Day RO
    Aust Fam Physician; 1987 Jun; 16(6):799, 803, 805 passim. PubMed ID: 3499886
    [No Abstract]   [Full Text] [Related]  

  • 24. New standards in arthritis care. Proceedings of an ILAR symposium. Rio de Janeiro, Brazil, September 18, 1989.
    J Rheumatol Suppl; 1990 Feb; 20():1-53. PubMed ID: 2325050
    [No Abstract]   [Full Text] [Related]  

  • 25. Hospitalization for gastrointestinal adverse events attributable to the use of low-dose aspirin among patients 50 years or older also using non-steroidal anti-inflammatory drugs: a retrospective cohort study.
    Rahme E; Nedjar H; Bizzi A; Morin S
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1387-98. PubMed ID: 17892525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Side effects of anti-inflammatory analgesics].
    Tiula E
    Duodecim; 1986; 102(22):1725-31. PubMed ID: 3492359
    [No Abstract]   [Full Text] [Related]  

  • 27. The management of NSAIDs therapy: how to minimize upper gastrointestinal tract damage.
    Lisotti A; Grenci C; Caponi A; Roda E
    Minerva Gastroenterol Dietol; 2008 Dec; 54(4):323-9. PubMed ID: 19047972
    [No Abstract]   [Full Text] [Related]  

  • 28. [Allergy to non steroidal anti-inflammatory drugs].
    Magnan A
    Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S66-10S69. PubMed ID: 17127969
    [No Abstract]   [Full Text] [Related]  

  • 29. Rates of serious gastrointestinal events from low dose use of acetylsalicylic acid, acetaminophen, and ibuprofen in patients with osteoarthritis and rheumatoid arthritis.
    Fries JF; Bruce B
    J Rheumatol; 2003 Oct; 30(10):2226-33. PubMed ID: 14528521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of low-dose aspirin: emphasis on outliers undermines the credibility of the conclusions.
    Graham DY
    Aliment Pharmacol Ther; 2007 Feb; 25(3):345-6; author reply 346-7. PubMed ID: 17217449
    [No Abstract]   [Full Text] [Related]  

  • 31. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
    Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastrointestinal side-effects of traditional non-steroidal anti-inflammatory drugs and new formulations.
    Lazzaroni M; Bianchi Porro G
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 2():48-58. PubMed ID: 15335413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Balancing benefits and harms: the example of non-steroidal anti-inflammatory drugs.
    Dieppe P; Bartlett C; Davey P; Doyal L; Ebrahim S
    BMJ; 2004 Jul; 329(7456):31-4. PubMed ID: 15231619
    [No Abstract]   [Full Text] [Related]  

  • 34. Assessment and prevention of gastrointestinal toxicity of non-steroidal anti-inflammatory drugs.
    Lane ME; Kim MJ
    J Pharm Pharmacol; 2006 Oct; 58(10):1295-304. PubMed ID: 17034651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of antirheumatic agents on the gastrointestinal tract].
    Otter K; Herrlinger JD; Ziegler A
    Med Monatsschr Pharm; 1998 Nov; 21(11):345-52. PubMed ID: 9835721
    [No Abstract]   [Full Text] [Related]  

  • 36. Minimizing risks of NSAIDs: cardiovascular, gastrointestinal and renal.
    Davies NM; Reynolds JK; Undeberg MR; Gates BJ; Ohgami Y; Vega-Villa KR
    Expert Rev Neurother; 2006 Nov; 6(11):1643-55. PubMed ID: 17144779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Famotidine to prevent peptic ulcer caused by NSAIDs.
    Singh G; Fries JF
    N Engl J Med; 1996 Oct; 335(17):1322; author reply 1322-3. PubMed ID: 8992334
    [No Abstract]   [Full Text] [Related]  

  • 38. [Drug-induced renal disorders in patients with rheumatoid arthritis].
    Nakano M; Nishi S; Ueno M; Saito T; Hasegawa H; Arakawa M
    Ryumachi; 1996 Oct; 36(5):775-82. PubMed ID: 8969558
    [No Abstract]   [Full Text] [Related]  

  • 39. [Analgesic intolerance and nasal polyps].
    Hosemann W; Kühnel T; Pfeifer M
    Laryngorhinootologie; 2000 Jan; 79(1):53-65. PubMed ID: 10689683
    [No Abstract]   [Full Text] [Related]  

  • 40. Non-steroidal anti-inflammatory drugs associated with gastroduodenal injury and Helicobacter pylori.
    Mizokami Y; Tamura K; Fukuda Y; Yamamoto I; Shimoyama T
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S109-12. PubMed ID: 7735925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.